| Zoledronic Acid studied in …STUDIED_INderived178 of 178show fewer |
|---|
| → studied in | NCT07823751NA · completed The Role of Bisphosphonate and Simvastatin Combination on Therapeutic Response in Breast Cancer With Bone Metastasis Via Dicckopf-1 Pathway · 178 trials list this drug (10 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03664687Phase 4 · completed Comparing a Single-Dose vs. Twice Yearly Zoledronate in Patients With Early Stage Breast Cancer (REaCT-ZOL) · 178 trials list this drug (10 active) | — | — | Early Stage Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06625190Phase 1/Phase 2 · recruiting Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors · 178 trials list this drug (10 active) | — | — | Chordoma,Rhabdoid Tumor,Wilms Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03958565recruiting Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations. · 178 trials list this drug (10 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03295981Phase 3 · recruiting Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone · 178 trials list this drug (10 active) | — | — | Giant Cell Tumor of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06374459Phase 1/Phase 2 · recruiting Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis · 178 trials list this drug (10 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03173976Phase 1 · active not recruiting Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial · 178 trials list this drug (10 active) | — | — | Chondrosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02508038Phase 1 · recruiting Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors · 178 trials list this drug (10 active) | — | — | Primitive Neuroectodermal Tumor,Acute Lymphoblastic Leukemia,Ewing Sarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00470223Phase 3 · active not recruiting Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma · 178 trials list this drug (10 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03073785Phase 2 · active not recruiting Hypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic Cancer · 178 trials list this drug (10 active) | — | — | Pancreatic Carcinoma,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01671774Phase 1 · completed Safety and Activity of IMAB362 in Combination With Zoledronic Acid and Interleukin-2 in CLDN18.2-positive Gastric Cancer · 178 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00365105Phase 3 · completed Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer · 178 trials list this drug (10 active) | — | — | Malignant Neoplasm,Malignant Breast Neoplasm,Malignant Lung Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03336983Phase 2 · completed Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients · 178 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00733538Phase 4 · completed Stage I Multiple Myeloma Treatment · 178 trials list this drug (10 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00295646Phase 3 · completed Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06221072Phase 3 · not yet recruiting A Study to Assess the Prevention of Bone-related Events in Patients With Bone Metastases From Malignant Solid Tumors Treated With JMT103 Compared to Zoledronic Acid · 178 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03358017Phase 2 · completed Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer · 178 trials list this drug (10 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00172029Phase 4 · completed Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid · 178 trials list this drug (10 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00556374Phase 3 · completed Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05866172Phase 3 · unknown HAIC Combined Withzoledronic Acid for the Prevention of Bone Metastases in Advanced HCC · 178 trials list this drug (10 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00268476Phase 2/Phase 3 · active not recruiting Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy · 178 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00885326Phase 1 · completed N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma · 178 trials list this drug (10 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00412022Phase 3 · unknown HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer. · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02286830Phase 4 · completed Prolonged Protection From Bone Disease in Multiple Myeloma · 178 trials list this drug (10 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00321464Phase 3 · completed A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects. · 178 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01345019Phase 3 · completed Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma · 178 trials list this drug (10 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Malignant Neoplasm,Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00330759Phase 3 · completed Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma. · 178 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00458796NA · terminated Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone · 178 trials list this drug (10 active) | — | — | Malignant Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00566618Phase 1/Phase 2 · completed Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis · 178 trials list this drug (10 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02739555Phase 3 · terminated Zoledronic Acid Compared to Percutaneous Treatment in Osteoid Osteoma · 178 trials list this drug (10 active) | — | — | Osteoid Osteoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05164952Phase 3 · unknown Delayed Versus Immediate Use Of Zoledronic Acid For Postmenopausal Patients With Early Breast Cancer Who Are Using Adjuvant Letrozole · 178 trials list this drug (10 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01951586Phase 2 · completed Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer · 178 trials list this drug (10 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04045522unknown Study on Bisphosphonates Targeting Triple-negative Breast Cancer · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00127205Phase 3 · completed S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer. · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01623908NA · terminated Bone Loss Treatment From Adjuvant Zoledronate Efficacy · 178 trials list this drug (10 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00622505Phase 4 · completed Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Participants · 178 trials list this drug (10 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00424983Phase 1 · completed Study of Zoledronic Acid Administered Monthly Versus Every 3 Months in Multiple Myeloma and Breast Cancer Patients Who Were Treated With Zoledronic Acid the Prior Year · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm,Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00058188Phase 3 · terminated Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation · 178 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02721433Phase 4 · completed 4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04325776Phase 2 · unknown A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metastasis · 178 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00079001Phase 3 · completed Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases · 178 trials list this drug (10 active) | — | — | Malignant Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00295867Phase 2 · completed Zoledronate in Treating Bone Marrow Micrometastases in Women With Stage I, Stage II, or Stage III Breast Cancer · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01409811NA · terminated Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic Acid · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm,Invasive Breast Carcinoma of No Special Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01087008Phase 4 · completed Zoledronic Acid in Patients With Multiple Myeloma and Asymptomatic Biochemical Relapse · 178 trials list this drug (10 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00305695Phase 2 · completed Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries · 178 trials list this drug (10 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00226954Phase 2 · terminated Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer · 178 trials list this drug (10 active) | — | — | Urinary Tract Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01099436Phase 3 · completed Neo-Adjuvant Chemotherapy (TAC) With or Without Zoledronic Acid in Treating HER2-negative Breast Cancer Patients · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00213980Phase 2 · completed Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00582556Phase 2 · completed Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy · 178 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00582790Phase 2 · terminated Study of IL2 in Combination With Zoledronic Acid in Patients With Kidney Cancer · 178 trials list this drug (10 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00987636Phase 3 · completed Study in Localized and Disseminated Ewing Sarcoma · 178 trials list this drug (10 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00436917NA · completed Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast Cancer · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01006395Phase 2/Phase 3 · completed Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT) · 178 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03932071Phase 4 · unknown Zoledronic Acid in Decrease the Lung Metastatic Rate of Osteosarcoma · 178 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00130494Phase 3 · terminated Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone Lesions · 178 trials list this drug (10 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02480634Phase 4 · unknown Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer · 178 trials list this drug (10 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00869206Phase 3 · completed Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement · 178 trials list this drug (10 active) | — | — | Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02347163Phase 2 · terminated Pre-operative Zoledronate in Triple Negative Breast Cancer · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01194440Phase 2 · completed Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm,Breast Ductal Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00321620Phase 3 · completed Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer · 178 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02632903Phase 2 · withdrawn Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study · 178 trials list this drug (10 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00482378Phase 1/Phase 2 · completed Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain · 178 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00265200Phase 2 · terminated Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer · 178 trials list this drug (10 active) | — | — | Lung Neoplasm,Lung Non-Small Cell Carcinoma,Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00264082completed Assessment of Tartrate-Resistant Acid Phosphatase (TRAP) as a Bone Resorption Marker in Stage IV Breast Cancer Patients With Bone Metastasis · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00278434Phase 1 · terminated Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3 · 178 trials list this drug (10 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00193856Phase 3 · completed RADAR Trial - Randomised Androgen Deprivation and Radiotherapy · 178 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00063609Phase 4 · completed The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy · 178 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00086268Phase 3 · completed Non-small Cell Lung Cancer Study US75 (Z-PACT) · 178 trials list this drug (10 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00099177Phase 3 · terminated A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain · 178 trials list this drug (10 active) | — | — | Bone Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00099203Phase 3 · terminated A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease · 178 trials list this drug (10 active) | — | — | Bone Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02622607Phase 3 · unknown Preventive Effects of Zoledronic Acid on Bone Metastasis in Patients With Stage IIIB and IV Lung Cancer · 178 trials list this drug (10 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01907880Phase 4 · completed The ODYSSEY TRIAL Phase IV Trial Evaluating the Palliative Benefit of Pamidronate or Zoledronic Acid in Breast Cancer · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00375648Phase 3 · completed Efficacy and Safety of Zoledronic Acid in the Treatment of Bone Metastases-related Pain in Patients With Prostate Cancer · 178 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00219271Phase 4 · completed Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer · 178 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01204203Phase 2 · completed Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901) · 178 trials list this drug (10 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02069340NA · withdrawn Genetics in Predicting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid · 178 trials list this drug (10 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02784652Phase 2 · completed Efficacy of Radiotherapy in Combination With Zoledronic Acid in Bone Metastasis Patients With Gastrointestinal Tumors · 178 trials list this drug (10 active) | — | — | Digestive System Neoplasm,Malignant Digestive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00577642Phase 2 · completed Bone Marker Assessment of Multiple Myeloma Patients Treated With Aminobisphosphonates · 178 trials list this drug (10 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00321932Phase 2 · completed Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant · 178 trials list this drug (10 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00172055Phase 3 · completed Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy · 178 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00241111Phase 4 · completed Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis · 178 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00434447Phase 4 · completed Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases · 178 trials list this drug (10 active) | — | — | Bone Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00171639Phase 3 · completed The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting Osteoporosis · 178 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00237146Phase 4 · completed Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy · 178 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00242554Phase 4 · completed Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases · 178 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00434317Phase 4 · completed Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone Metastases · 178 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00334139Phase 4 · completed Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01920568Phase 3 · completed A Study to Compare Denosumab With Zoledronic Acid in Subjects With Bone Metastases From Solid Tumors · 178 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00107263Phase 3 · completed Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00172003Phase 4 · completed Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis · 178 trials list this drug (10 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00391690Phase 4 · completed Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate Cancer · 178 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00081159Phase 2 · completed Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases · 178 trials list this drug (10 active) | — | — | Malignant Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02739594Phase 3 · terminated Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple Myeloma · 178 trials list this drug (10 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00022087Phase 3 · completed Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00903162Phase 2 · completed Extended Endocrine Therapy for Premenopausal Women With Breast Cancer · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00889590Phase 2 · terminated Adjuvant Zoledronic Acid in High Risk Giant Cell Tumour of Bone (GCT) · 178 trials list this drug (10 active) | — | — | Giant Cell Tumor of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00202059Phase 3 · completed Effects of Zometa and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast Cancer · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02595138Phase 3 · unknown Zoledronic Acid as Adjuvant Treatment of Triple-negative Breast Cancer · 178 trials list this drug (10 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00685646Phase 3 · completed Androgen Blockade Therapy With or Without Zoledronic Acid in Treating Patients With Prostate Cancer and Bone Metastases · 178 trials list this drug (10 active) | — | — | Malignant Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00966992Phase 2 · terminated Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer · 178 trials list this drug (10 active) | — | — | Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00375505Phase 3 · completed The Safety and Efficacy of Zoledronic Acid in the Prevention of Cancer Therapy Induced Bone Loss · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00083382Phase 2 · completed Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide · 178 trials list this drug (10 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01344967Phase 2/Phase 3 · completed Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Patients With Metastatic Breast Cancer: Duration of Effect · 178 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00172042Phase 3 · completed A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC) · 178 trials list this drug (10 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01062503completed Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic CRPC · 178 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00219219Phase 4 · completed Zoledronic Acid in the Prevention of Skeletal-related Events in Hormone Refractory and Hormone-sensitive Prostate Cancer Patients With Bone Metastases · 178 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00242528Phase 4 · withdrawn Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma. · 178 trials list this drug (10 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00512993Phase 3 · completed Postoperative Use of Zoledronic Acid in Breast Cancer Patients After Neoadjuvant Chemotherapy · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00151073Phase 2 · completed Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate · 178 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01404702Phase 1 · terminated Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma · 178 trials list this drug (10 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00333229Phase 4 · terminated A Study of Zoledronic Acid in the Prevention of Cancer Therapy-induced Bone Loss · 178 trials list this drug (10 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00892242Phase 1 · terminated Perioperative Treatment With Zoledronic Acid in Patients With Resectable Pancreas Cancer · 178 trials list this drug (10 active) | — | — | Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00320710Phase 3 · completed Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00972959Phase 2 · completed Effect of Combination of Bortezomib/Dexamethasone/Zoledronic Acid on Bone Disease in Patients With Multiple Myeloma Relapsed After 1-3 Prior Lines of Therapy · 178 trials list this drug (10 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00742924Phase 1 · completed Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma · 178 trials list this drug (10 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01129336Phase 4 · completed Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients · 178 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00242567Phase 3 · completed Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer · 178 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00712985Phase 3 · completed Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL) · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00215943Phase 3 · terminated Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD) · 178 trials list this drug (10 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00033332Phase 3 · completed Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma · 178 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00050011Phase 3 · completed Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy · 178 trials list this drug (10 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049452Phase 3 · completed Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00762346Phase 4 · completed Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis · 178 trials list this drug (10 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00301886Phase 3 · withdrawn S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone · 178 trials list this drug (10 active) | — | — | Malignant Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00242203Phase 2 · completed Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast Cancer · 178 trials list this drug (10 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00554918Phase 2 · completed Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy · 178 trials list this drug (10 active) | — | — | Malignant Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00072020Phase 3 · unknown Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer · 178 trials list this drug (10 active) | — | — | Malignant Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00181584Phase 2 · completed Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer · 178 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00588913Phase 1/Phase 2 · completed Adoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung Metastases · 178 trials list this drug (10 active) | — | — | Malignant Neoplasm,Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00352846Phase 3 · completed Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss · 178 trials list this drug (10 active) | — | — | Lymphoma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004928Phase 1 · completed Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer · 178 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00039104Phase 2 · completed Zoledronate and BMS-275291 in Treating Patients With Prostate Cancer · 178 trials list this drug (10 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00558272Phase 2 · completed Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm,Bone Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00060138Phase 1/Phase 2 · completed Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases · 178 trials list this drug (10 active) | — | — | Malignant Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005073Phase 3 · terminated Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms · 178 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00873808withdrawn S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307 · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00114270NA · completed Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast Density · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00490698Phase 2 · completed Zoledronate With Atorvastatin in Renal Cell Carcinoma · 178 trials list this drug (10 active) | — | — | Malignant Kidney Neoplasm,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00326820Phase 3 · unknown Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer · 178 trials list this drug (10 active) | — | — | Malignant Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003884Phase 3 · completed Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone · 178 trials list this drug (10 active) | — | — | Malignant Neoplasm,Adult Solid Neoplasm,Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00301873Phase 2 · completed Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma · 178 trials list this drug (10 active) | — | — | Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00741377Phase 1 · completed A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients · 178 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00258258Phase 1 · terminated Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders · 178 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01004510Phase 2 · terminated Zometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung Cancer · 178 trials list this drug (10 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00432458Phase 3 · completed Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma · 178 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00294437Phase 3 · terminated ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases · 178 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00172016Phase 4 · completed A Study to Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can be Treated With a Group of Medications Known as Bisphosphonates · 178 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00171340Phase 3 · completed Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer. · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00171314Phase 3 · completed The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00171925Phase 3 · terminated Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I · 178 trials list this drug (10 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00375427Phase 3 · completed Safety and Efficacy of Zoledronic Acid in Patients With Breast Cancer With Metastatic Bone Lesions · 178 trials list this drug (10 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00697619Phase 2 · completed To Evaluate the Efficacy of ZOMETA® in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal Cancer · 178 trials list this drug (10 active) | — | — | Malignant Nasopharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00029224Phase 4 · completed Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm,Multiple Myeloma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00760370Phase 2 · completed Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm,Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00126386NA · completed Zometa for the Management of Tumor-induced Hypercalcemia and Malignant Bone Pain in the Community · 178 trials list this drug (10 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00332709Phase 3 · completed Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer · 178 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00376740Phase 3 · completed Effectiveness of Zoledronic Acid in the Prevention of Osteoporosis in Early Breast Cancer Patients Receiving Letrozole · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00263484Phase 2 · completed Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma · 178 trials list this drug (10 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00104104Phase 4 · completed A Multiple Myeloma Trial in Patients With Bone Metastases · 178 trials list this drug (10 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00691236Phase 2/Phase 3 · unknown Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma · 178 trials list this drug (10 active) | — | — | Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00216151Phase 2 · terminated Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma · 178 trials list this drug (10 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01341262Phase 2 · completed THAL-DEX Incorporated Into Double PBSC Autotransplantation for Untreated Multiple Myeloma (MM) · 178 trials list this drug (10 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00237159Phase 4 · completed Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastasis · 178 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00264420Phase 1 · completed Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm,Malignant Lung Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01234129completed Stem Cell Transplant and Zoledronic Acid Improve Outcome in Previously Untreated Patients With Multiple Myeloma · 178 trials list this drug (10 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00524849Phase 2/Phase 3 · completed Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasis · 178 trials list this drug (10 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00181558Phase 2 · completed Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone · 178 trials list this drug (10 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00258765Phase 2 · terminated Adjuvant Docetaxel-Zoledronic Acid in High-risk Early Prostate Cancer Following Prostatectomy. · 178 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00415779Phase 1 · completed ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer · 178 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00912938Phase 4 · unknown Evaluate the Relationship of Bone Remodeling Markers for Skeletal Complications in Metastatic Breast Cancer Patients · 178 trials list this drug (10 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00035997Phase 4 · completed Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis · 178 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00087659NA · completed A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy · 178 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00099541Phase 4 · completed Non-small Cell Lung Cancer Registry · 178 trials list this drug (10 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00219258Phase 3 · completed Efficacy and Safety of Zoledronic Acid in Patients With Bone Metastases of Any Solid Tumors or Multiple Myeloma · 178 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00372710Phase 3 · terminated Safety/Efficacy of Intravenous Zoledronic Acid When Added to Standard Therapies in Patients With Breast Cancer and Metastatic Bone Lesions · 178 trials list this drug (10 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00391950Phase 3 · terminated Maintaining Bone Strength in Men With Prostate Cancer · 178 trials list this drug (10 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00636740Phase 2 · completed Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer Patients · 178 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00520052NA · completed Frequency of Zoledronic Acid to Prevent Further Bone Loss in Osteoporotic Patients Requiring Androgen Deprivation Therapy for Prostate Cancer · 178 trials list this drug (10 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |